Just before the stock market opened on Tuesday, President Donald Trump tweeted that he is working on “a new system” to reduce prices, adding that he’ll bring “competition” to the drug industry. It’s not the first time comments from Trump have had a big effect on pharmaceutical stocks, but he hasn’t gotten into specifics and investors aren’t sure how committed he is to doing something.